| Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) (NCT07453888) | Dompé Farmaceutici S.p.A | 2026-07-01 |
| An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED (NCT07519902) | Dompé Farmaceutici S.p.A | 2026-06-02 |
| An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease (NCT07503886) | Dompé Farmaceutici S.p.A | 2026-05-12 |
| An Efficacy and Safety Study of DFL24498 in the Treatment of AKC (NCT07395232) | Dompé Farmaceutici S.p.A | 2025-12-01 |
| Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye (NCT06411132) | Dompé Farmaceutici S.p.A | 2024-05-09 |
| Open-label Trial to Evaluate Efficacy and Safety of rhNGF on Corneal Thickness Via AS-OCT in Neurotrophic Keratitis (NCT06411145) | Dompé Farmaceutici S.p.A | 2024-04-26 |
| A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease. (NCT06244316) | Dompé Farmaceutici S.p.A | 2024-01-22 |
| DEFENDO Long Term Follow-up Study in Stage 1 NK Patients (NCT05552261) | Dompé Farmaceutici S.p.A | 2023-02-01 |
| Add-on Reparixin in Adult Patients With ARDS (NCT05496868) | Dompé Farmaceutici S.p.A | 2022-12-06 |
| Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes. (NCT05368402) | Dompé Farmaceutici S.p.A | 2022-09-14 |
| Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia (NCT05254990) | Dompé Farmaceutici S.p.A | 2022-04-27 |
| To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer (NCT05212701) | Dompé Farmaceutici S.p.A | 2022-04-19 |
| Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease (NCT05136170) | Dompé Farmaceutici S.p.A | 2022-01-27 |
| Safety and Efficacy Study on Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease (PROTEGO-1 Study) (NCT05133180) | Dompé Farmaceutici S.p.A | 2022-01-19 |
| Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 Diabetes (NCT05035368) | Dompé Farmaceutici S.p.A | 2021-09-30 |
| Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia. (NCT04878055) | Dompé Farmaceutici S.p.A | 2021-02-14 |
| A Study on Ketoprofen Lysine Salt (KLS) + Gabapentin (GABA) vs KLS to Investigate Their Pharmacodynamic in Healthy Males (NCT04802967) | Dompé Farmaceutici S.p.A | 2021-02-08 |
| Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients. (NCT05172050) | Dompé Farmaceutici S.p.A | 2021-01-22 |
| A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function (NCT04628481) | Dompé Farmaceutici S.p.A | 2021-01-12 |
| A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline. (NCT04899271) | Dompé Farmaceutici S.p.A | 2020-12-14 |
| A Single Dose Study About the Influence of Food on the Oral Bioavailability of Ladarixin Capsule in Healthy Volunteers (NCT04854642) | Dompé Farmaceutici S.p.A | 2020-10-20 |
| Study to Evaluate OXERVATE® in Patients With Stage 1 Neurotrophic Keratitis (NCT04485546) | Dompé Farmaceutici S.p.A | 2020-09-09 |
| A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye (NCT03982368) | Dompé Farmaceutici S.p.A | 2019-06-10 |
| Ascending Dose Tolerability Trial and PK Assessment in Healthy Volunteers After Single & Multiple Oral Intake of DF2755A (NCT04803396) | Dompé Farmaceutici S.p.A | 2018-11-15 |
| A Study to Assess Efficacy and Tolerability of Ketoprofen 40 mg Granules vs Placebo (NCT03836807) | Dompé Farmaceutici S.p.A | 2018-04-04 |
| Study to Evaluate Safety, Tolerability & PK of rhNGF in Healthy Volunteers (NCT03836859) | Dompé Farmaceutici S.p.A | 2018-03-30 |